Generate a tailored SOP for Dr. Alborz Jooya. Improve your application with a focused, well-structured draft.
Dr. Jooya is engaged in cutting-edge research utilizing MR-LINAC technology, with a particular emphasis on stereotactic radiotherapy for breast, gastrointestinal (GI), genitourinary (GU), and oligometastatic cancers. His research integrates clinical oncology focusing on breast, GI, and GU malignancies and aims to incorporate MR-LINAC-based treatments into standard practice. Dr. Jooya is committed to advancing oncology research by contributing to innovative cancer treatment strategies. His research interests include the application of ablative radiotherapy as a treatment modality for primary and metastatic malignancies through stereotactic body radiotherapy (SBRT) using the MR-Linac System. This includes feasibility studies of ablative treatments for GI cancers, such as liver and GU tumors, specifically prostate and kidney cancers. A core component of his MR-LINAC research involves developing practice-based training strategies for transitioning radiation oncologists to therapist-driven adaptive SBRT using the MR-Linac System. Furthermore, Dr. Jooya aims to increase the use of MR-LINAC technology in managing patients with oligometastatic upper gastrointestinal malignancies and to assess health-related Quality of Life (HRQOL) outcomes for patients receiving SBRT with MR-LINAC systems, addressing the knowledge gap in the collection and analysis of prospectively collected QOL data.
Department of Computer Science Master's program. GRE scores are expected for international students.